On the other hand, in the last decade, several molecules called “CFTR modulators” (also nicknamed “caftors”), which partially restore the activity of the CFTR protein, have been developed and are now increasingly used for alleviating the clinical conditions of many CF patients. This evidence concerns the gene CFTR and cystic fibrosis.